Trial Profile
Investigation of efficacy of decitabine in patients with acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2016
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Aclarubicin; Cytarabine; Daunorubicin; Idarubicin; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 20 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology